Third Harmonic Bio
THRD
THRD was delisted on the 30th of July, 2025.
71 hedge funds and large institutions have $358M invested in Third Harmonic Bio in 2024 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 20 increasing their positions, 18 reducing their positions, and 7 closing their positions.
129% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 7
15% more funds holding
Funds holding: 62 → 71 (+9)
11% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 18
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.39% less ownership
Funds ownership: 94.43% → 93.05% (-1.4%)
14% less capital invested
Capital invested by funds: $418M → $358M (-$60.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Boxer Capital
San Diego,
California
|
+$12.2M |
| 2 |
CC
Commodore Capital
New York
|
+$5.28M |
| 3 |
Millennium Management
New York
|
+$2.48M |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$2.04M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$819K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
B
Braidwell
Stamford,
Connecticut
|
-$14.4M |
| 2 |
JP Morgan Chase
New York
|
-$5.56M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$3.98M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$2.91M |
| 5 |
Morgan Stanley
New York
|
-$2.48M |
THRD Hedge Fund Activity: Q1 2024 in Review
71 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Third Harmonic Bio (THRD) for Q1 2024, worth a combined $358M — down 14% from $418M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new THRD positions and 7 closed out — a net gain of 9 holders — while 20 added to existing stakes and 18 trimmed.
The largest buyer was Boxer Capital, adding an estimated $12.2M. The largest seller was Braidwell, exiting entirely with an estimated $14.4M sold.
- 71 institutional investors held Third Harmonic Bio (THRD) as of Q1 2024, up from 62 in Q4 2023.
- Funds reported $358M of Third Harmonic Bio stock for Q1 2024, down 14% quarter-over-quarter.
- 16 funds opened new Third Harmonic Bio positions in Q1 2024 and 7 closed out, a net change of +9 holders.
- The largest Third Harmonic Bio buyer in Q1 2024 was Boxer Capital, an estimated $12.2M added.
- The largest Third Harmonic Bio seller in Q1 2024 was Braidwell, an estimated $14.4M sold.
Based on aggregated 13F filings for Q1 2024.